Keenova Therapeutics plc - Company Profile
Powered by 
All the sales intelligence you need on Keenova Therapeutics plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Keenova Therapeutics plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Keenova Therapeutics plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Keenova Therapeutics plc (Keenova), formerly Mallinckrodt Plc, develops, manufactures, markets, and distributes generic and branded specialty pharmaceutical products and therapies. Manufacturing and supply chain capabilities, strong market position and brand recognition, and diversified product portfolio are its strengths, even as over-dependence on the US region could be a major cause for concern. Keenova could benefit from the growing incidence of cancer, enhancing its international footprint, and the global cardiovascular device market. However, high competition, reliance on third-party suppliers, and stringent regulations could limit its growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer